Publications by authors named "Ali Sahra"

Claim this Profile
O
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.
Alex Rampotas, Luke Carter-Brzezinski, Tim C P Somervaille, James Forryan, Fotios Panitsas, Ali Sahra

Blood· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
Nigel H Russell, Robert K Hills, Lars Kjeldsen, Richard E Clark, Sahra Ali

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective registry-based cohort study of the diagnosis and management of acute leukaemia in pregnancy: Study protocol.
Matthew Northgraves, David Allsup, Judith Cohen, Chao Huang, John Turgoose, Sahra Ali

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.
Jamie Saunders, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O'Sullivan, Claire Woodley, Sahra Ali

Hemasphere· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center.
Alesia Khan, Claire Woodley, Deepti Radia, George N Mikhaeel, Jessica Brady, Sahra Ali

Hemasphere· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Patrick Harrington, Claire N Harrison, Richard Dillon, Deepti H Radia, Katayoun Rezvani, Sahra Ali

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Paul Deschamps, Mufaddal Moonim, Deepti Radia, Natalia Curto-Garcia, Claire Woodley, Sahra Ali

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
Dragana Milojkovic, Nicholas C P Cross, Sahra Ali, Jenny Byrne, Gavin Campbell

Br J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma.
Sahra Ali, Jorge Camarero, Paulavan Hennik, Bjorg Bolstad, Maja Sommerfelt Grønvold

ESMO Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma.
Irene Papadouli, Jan Mueller-Berghaus, Claire Beuneu, Sahra Ali, Benjamin Hofner

Oncologist· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Dominik Karres, Sahra Ali, Paula B van Hennik, Sabine Straus, Filip Josephson

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
Sahra Ali, Alexandre Moreau, Daniela Melchiorri, Jorge Camarero, Filip Josephson

Oncologist· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Sahra Ali, Rune Kjeken, Christiane Niederlaender, Greg Markey, Therese S Saunders

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN.
Claire Harrison, Jonathan Mathias, Maz Campbell-Drew, Adam J Mead, Zack Pemberton-Whiteley, Sahra Ali

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia.
Sahra Ali, Helen-Marie Dunmore, Dominik Karres, Justin L Hay, Tomas Salmonsson

Oncologist· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Nicholas C P Cross, Yvette Hoade, William J Tapper, Gonzalo Carreno-Tarragona, Tiziana Fanelli, Sahra Ali

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.
Mary F F McMullin, Adam J Mead, Sahra Ali, Catherine Cargo, Frederick Chen

Br J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline.
Mary Frances McMullin, Claire N Harrison, Sahra Ali, Catherine Cargo, Frederick Chen

Br J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Claire N Harrison, Adam J Mead, Anesh Panchal, Sonia Fox, Christina Yap, Sahra Ali

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline for the investigation and management of eosinophilia.
Nauman M Butt, Jonathan Lambert, Sahra Ali, Philip A Beer, Nicholas C P Cross

Br J Haematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy.
Sahra Ali, Gail L Jones, Dominic J Culligan, Philippa J Marsden, Nigel Russell

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial.
Adam J Mead, Dragana Milojkovic, Steven Knapper, Mamta Garg, Joseph Chacko, Sahra Ali

Br J Haematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.
Alan K Burnett, Nigel H Russell, Ann E Hunter, Donald Milligan, Steven Knapper, Sahra Ali

Blood· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.
Nils Winkelmann, Claire Hidalgo-Curtis, Katherine Waghorn, Joannah Score, Helen Dickinson, Sahra Ali

Leuk Lymphoma· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased inducible heat shock protein 72 expression associated with PBMC isolated from patients with haematological tumours.
Leigh A Madden, Yvette A Hayman, Corrinna Underwood, Rebecca V Vince, John Greenman, Sahra Ali

Scand J Clin Lab Invest· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis